Anti-inflammatory MG phenotype can be assessed by the expression of surface marker, macrophage mannose receptor 1 (CD206), and the upregulation of anti−inflammatory molecules, including IL− 10, arginase−1 (Arg1), Ym1, and TGF−β. Here, ARG1 is linked to myasthenia gravis.